In second-trimester Down syndrome pregnancies, levels of inhibin-A (the alpha-betaA dimer) in maternal serum and amniotic fluid (AF) are significantly higher and lower than in normal pregnancy, respectively. Since AF also contains inhibin-B (the alpha-betaB dimer) and precursor inhibins, we have exa
Inhibin A and pro-αC inhibin in Down syndrome and normal pregnancies
✍ Scribed by Donato D'Antona; Euan M. Wallace; Catherine Shearing; J. Peter Ashby; Nigel P. Groome
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 141 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
✦ Synopsis
Using two enzyme-linked immunosorbent assays specific for inhibin A and pro-C inhibin, levels of the two proteins were assessed in maternal serum from 43 Down syndrome and 300 chromosomally normal pregnancies at 15-17 weeks' gestation. Compared to the control pregnancies, both inhibin A and pro-C inhibin were significantly elevated in the Down syndrome pregnancies with median levels, expressed as multiples of the normal median, of 1•53 MoM and 1•34 MoM, respectively (P<0•001 and P=0•046 compared to controls). Levels of inhibin A and pro-C inhibin were weakly but significantly correlated in both the control and the Down syndrome sera (r=0•25, P<0•0001; r=0•4, P=0•008, respectively). These data suggest that the mechanism(s) underlying the elevated inhibin levels observed in Down syndrome may affect the regulation of both the inhibin -and A -subunits.
📜 SIMILAR VOLUMES
a High risk=sampled prior to invasive prenatal diagnosis. b Indication for invasive prenatal diagnosis: history=previous pregnancy with Edwards' syndrome; screening=positive maternal serum screening test. c With hydrops. d With cystic hygroma.
A nested case-control study using stored serum samples collected as part of a prospective study of the outcome of pregnancy was performed to investigate concentrations of (dimeric) inhibin-A in maternal serum between 15 and 22 weeks of pregnancy in 200 twin pregnancies and 600 singleton control preg
A nested case-control study using stored serum samples collected as part of a prospective study of the outcome of pregnancy was performed to investigate concentrations of (dimeric) inhibin-A in maternal serum between 15 and 22 weeks of pregnancy in 126 pregnancies among 92 women with insulin-depende
Initial studies of immunoreactive inhibin using a commercial assay have shown levels to be increased in three second-trimester series of maternal samples from Down's syndrome-affected pregnancies. This assay detected non-specifically all forms of circulating inhibin, dimeric and free alpha subunits,